Report Reveals Dramatic Increase in Medication Errors Involving Drugs with Names that Look or Sound Alike

The 8th annual national MEDMARX(R) Data Report released last month by the U.S. Pharmacopeia (USP) revealed that more than 1,400 commonly used drugs are involved in errors linked to drug names that look alike or sound alike. USP’s review revealed a near doubling since 2004 of the pairs of drug names that look or sound alike, from 1,750 pairs to … Read the rest

FDA Issues Public Health Advisory on Chantix, Which May Become the Subject of Product Liability Suits

The U.S. Food and Drug Administration (FDA) on February 1, 2008, issued a Public Health Advisory to alert health care providers, patients, and caregivers to new safety warnings concerning Chantix (varenicline), a prescription medication used to help patients stop smoking.

Serious neuropsychiatric symptoms have occurred in patients taking Chantix. These symptoms include changes in behavior, agitation, depressed mood, suicidal ideation, … Read the rest

Drug Makers Release Test Results That Shows That Their Cholesterol Drug Zetia Has No Benefits

Merck and Schering- Plough, the makers of the popular cholesterol drug, Zetia, announced that Zetia and Vytorin, a pill containing Zetia and Zocor, had failed to benefit patients of a two-year trial which was completed in April of 2006. Merck and Schering-Plough’s press release stated that Zetia not only failed to slow down the accumulation of fatty plaque in … Read the rest

Plaintiffs’ Attorneys’ Motions Challenging Vioxx Settlement Cloud Issues as January 15, 2008 Deadline to Register Approaches

Pursuant to the terms of the $4.85 billion Vioxx settlement, January 15, 2008 is the deadline for all plaintiffs with a Vioxx-related case to register — whether or not their injuries would necessarily qualify for the settlement payout. This preliminary step will establish how many cases Merck, the manufacturer of Vioxx, faces. Those that don’t qualify for the settlement … Read the rest

FDA’s Rule Pre-empting State Law Failure-to-Warn Claim is Rejected

On July 3rd, the Vioxx multidistrict litigation court held that the Food and Drug Administrations (FDA)’s rule preempting state products liability law suits against drug companies in failure-to-warn claims is not persuasive. The court also stated that FDA cannot assume that Congress intended to override the long-standing presumption against preempting state law.

The court’s ruling is a victory for consumers … Read the rest

Drug Companies Will Be Forced To List Gifts Made To Doctors If Legislation Passes

On June 27th, a Senate hearing was held regarding the pharmaceutical industry’s routine practice of promoting and marketing drugs and medical devices by showering doctors with gifts. Drug companies which attempt to persuade doctors to prescribe their drugs provide doctors with meals at high-priced restaurants, stock options, sponsorships for educational programs, drug samples, tickets to sporting events and Broadway … Read the rest

Focus on Drug-Makers’ Marketing

The news last week was filled with various reports concerning the manner in which pharmaceutical manufacturers market their products, such as OxyContin, anemia medicines, and atypical psychotics, including ways in which doctors are encouraged to prescribe their products, even to children. The U.S. Senate passed, by a vote of 93-1, a bill that gives the Food and Drug Administration additional … Read the rest